HUB Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Buy
27,433
+3,143
+13% +$183K 0.04% 275
2025
Q4
$1.31M Buy
+24,290
New +$1.17M 0.03% 258
2025
Q3
Sell
-18,898
Closed -$875K 862
2025
Q2
$875K Buy
18,898
+2,612
+16% +$128K 0.03% 285
2025
Q1
$993K Sell
16,286
-512
-3% -$29.8K 0.04% 233
2024
Q4
$950K Buy
16,798
+2,835
+20% +$158K 0.04% 217
2024
Q3
$722K Buy
13,963
+1,219
+10% +$57.2K 0.03% 240
2024
Q2
$529K Buy
12,744
+1,145
+10% +$51.2K 0.02% 270
2024
Q1
$629K Buy
11,599
+341
+3% +$17.4K 0.03% 239
2023
Q4
$578K Buy
11,258
+5,604
+99% +$294K 0.04% 221
2023
Q3
$328K Buy
5,654
+768
+16% +$47.1K 0.05% 185
2023
Q2
$312K Sell
4,886
-434
-8% -$29.1K 0.05% 188
2023
Q1
$369K Buy
5,320
+657
+14% +$46.3K 0.08% 153
2022
Q4
$335K Sell
4,663
-38
-0.8% -$2.87K 0.07% 102
2022
Q3
$334K Sell
4,701
-30,687
-87% -$2.23M 0.1% 129
2022
Q2
$2.73M Buy
35,388
+1,923
+6% +$146K 0.85% 27
2022
Q1
$2.44M Sell
33,465
-653
-2% -$43.8K 0.58% 44
2021
Q4
$2.13M Buy
34,118
+1,450
+4% +$85.1K 0.49% 56
2021
Q3
$1.93M Buy
32,668
+1,689
+5% +$111K 0.46% 62
2021
Q2
$2.07M Buy
30,979
+5,137
+20% +$335K 0.55% 53
2021
Q1
$1.63M Buy
25,842
+6,219
+32% +$387K 0.48% 59
2020
Q4
$1.18M Buy
+19,623
New +$1.21M 0.54% 54

Other funds holding BMY

HUB Investment Partners's BMY Position: Q1 2026 in Review

HUB Investment Partners increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $183K and bringing the position to 27,433 shares worth $1.66M. The position accounts for 0.04% of the portfolio, ranked #275.

HUB Investment Partners first reported a position in BMY in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.73M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • HUB Investment Partners held 27,433 shares of Bristol-Myers Squibb worth $1.66M as of Q1 2026.
  • HUB Investment Partners bought 3,143 Bristol-Myers Squibb shares in Q1 2026, an estimated $183K.
  • Bristol-Myers Squibb made up 0.04% of HUB Investment Partners's portfolio in Q1 2026, its #275 holding.
  • HUB Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 21 quarters since.
  • HUB Investment Partners's Bristol-Myers Squibb position peaked at $2.73M in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.